High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes 20-Year Follow-up of a Phase 3 Randomized Clinical Trial

T.G. Steenbruggen, L.C. Steggink, C.M. Seynaeve, J.J.M. van der Hoeven, M.J. Hooning, A. Jager, I.R. Konings, J.R. Kroep, W.M. Smit, V.C.G. Tjan-Heijnen, E. van der Wall, A.D. Bins, S.C. Linn, M. Schaapveld, J.N. Jacobse, F.E. van Leeuwen, C.P. Schroder, H. van Tinteren, E.G.E. de Vries, G.S. SonkeJ.A. Gietema

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)528-534
Number of pages7
JournalJAMA Oncology
Volume6
Issue number4
DOIs
Publication statusPublished - 1 Apr 2020

Keywords

  • benefit
  • conventional adjuvant chemotherapy
  • cyclophosphamide
  • efficacy
  • epirubicin
  • recurrence
  • support
  • therapy
  • women
  • CONVENTIONAL ADJUVANT CHEMOTHERAPY
  • EFFICACY
  • CYCLOPHOSPHAMIDE
  • SUPPORT
  • WOMEN
  • BENEFIT
  • EPIRUBICIN
  • THERAPY
  • RECURRENCE

Cite this